Balyasny Asset Management’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-24,253
Closed -$69.8K 2335
2024
Q1
$69.8K Buy
+24,253
New +$69.8K ﹤0.01% 1889
2016
Q2
Sell
-130
Closed -$108K 1191
2016
Q1
$108K Sell
130
-16
-11% -$13.3K ﹤0.01% 994
2015
Q4
$153K Sell
146
-2
-1% -$2.1K ﹤0.01% 992
2015
Q3
$116K Sell
148
-209
-59% -$164K ﹤0.01% 891
2015
Q2
$470K Buy
+357
New +$470K ﹤0.01% 637